Collectively, these findings demonstrate that deletion of FOXA1-SEs significantly inhibits SLC7A11-induced disulfidoptosis in prostate cancer cells (Supplementary Fig. 3E, F). Here, SLC7A11 is linked to prostate carcinoma.